Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 468-473, December 2009

Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab

  • Zhao Jing

      Affiliations

    • Department of Radiation Oncology, The First Affiliated Hospital of Wenzhou Medical College, China
  • ,
  • Ling Gong

      Affiliations

    • Department of Infection and Liver Diseases, The First Affiliated Hospital of Wenzhou Medical College, China
  • ,
  • Cong-Ying Xie

      Affiliations

    • Department of Radiation Oncology, The First Affiliated Hospital of Wenzhou Medical College, China
  • ,
  • Li Zhang

      Affiliations

    • Department of Radiation Oncology, The First Affiliated Hospital of Wenzhou Medical College, China
  • ,
  • Hua-Fang Su

      Affiliations

    • Department of Radiation Oncology, The First Affiliated Hospital of Wenzhou Medical College, China
  • ,
  • Xia Deng

      Affiliations

    • Department of Radiation Oncology, The First Affiliated Hospital of Wenzhou Medical College, China
  • ,
  • Shi-Xiu Wu

      Affiliations

    • Department of Radiation Oncology, The First Affiliated Hospital of Wenzhou Medical College, China
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China.

Received 23 January 2009; received in revised form 26 July 2009; accepted 11 August 2009. published online 10 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0167-8140(09)00445-9

doi:10.1016/j.radonc.2009.08.008

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 468-473, December 2009